Haifeng Ye

2.9k total citations
55 papers, 2.2k citations indexed

About

Haifeng Ye is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Biomedical Engineering. According to data from OpenAlex, Haifeng Ye has authored 55 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 14 papers in Cellular and Molecular Neuroscience and 11 papers in Biomedical Engineering. Recurrent topics in Haifeng Ye's work include CRISPR and Genetic Engineering (17 papers), Photoreceptor and optogenetics research (11 papers) and Pancreatic function and diabetes (9 papers). Haifeng Ye is often cited by papers focused on CRISPR and Genetic Engineering (17 papers), Photoreceptor and optogenetics research (11 papers) and Pancreatic function and diabetes (9 papers). Haifeng Ye collaborates with scholars based in China, Switzerland and Germany. Haifeng Ye's co-authors include Martin Fussenegger, Ren‐Wang Peng, Marie Daoud‐El Baba, Mingqi Xie, Ghislaine Charpin‐El Hamri, Jiawei Shao, Guiling Yu, Shuai Xue, Jianli Yin and Pratik Saxena and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Haifeng Ye

49 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haifeng Ye China 24 1.4k 647 641 285 229 55 2.2k
Mingqi Xie China 17 849 0.6× 254 0.4× 397 0.6× 85 0.3× 177 0.8× 34 1.3k
Hua Gao China 24 1.5k 1.0× 418 0.6× 350 0.5× 74 0.3× 69 0.3× 73 2.4k
Laura Mezzanotte Netherlands 25 1.1k 0.8× 278 0.4× 842 1.3× 64 0.2× 112 0.5× 73 2.0k
Marie Daoud‐El Baba Switzerland 14 1.2k 0.9× 252 0.4× 334 0.5× 146 0.5× 84 0.4× 19 1.5k
Hongyin Wang China 22 1.2k 0.8× 244 0.4× 408 0.6× 152 0.5× 70 0.3× 55 2.0k
Xiaoyu Chen China 26 3.2k 2.3× 241 0.4× 333 0.5× 293 1.0× 96 0.4× 90 3.8k
Claudia Seidel Germany 15 957 0.7× 142 0.2× 743 1.2× 203 0.7× 116 0.5× 17 2.2k
F Solomon United States 25 1.5k 1.1× 297 0.5× 574 0.9× 170 0.6× 141 0.6× 38 2.8k
Jung‐Eun Park South Korea 35 2.5k 1.8× 241 0.4× 323 0.5× 314 1.1× 42 0.2× 95 3.5k
Antonella Calogero Italy 29 1.4k 1.0× 322 0.5× 263 0.4× 57 0.2× 129 0.6× 84 2.6k

Countries citing papers authored by Haifeng Ye

Since Specialization
Citations

This map shows the geographic impact of Haifeng Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haifeng Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haifeng Ye more than expected).

Fields of papers citing papers by Haifeng Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haifeng Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haifeng Ye. The network helps show where Haifeng Ye may publish in the future.

Co-authorship network of co-authors of Haifeng Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Haifeng Ye. A scholar is included among the top collaborators of Haifeng Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haifeng Ye. Haifeng Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Zhihao, Di Dai, Xiaoding Ma, et al.. (2025). Engineered bacteria for near-infrared light-inducible expression of cancer therapeutics. Nature Cancer. 6(4). 612–628. 16 indexed citations
2.
Zhou, Yang, Yu Wei, Lei Li, Tao Yan, & Haifeng Ye. (2025). Optogenetics in medicine: innovations and therapeutic applications. Current Opinion in Biotechnology. 92. 103262–103262. 6 indexed citations
3.
Ma, Xiaoding, Jianli Yin, Yang Zhou, et al.. (2024). A programmable targeted protein-degradation platform for versatile applications in mammalian cells and mice. Molecular Cell. 84(8). 1585–1600.e7. 15 indexed citations
4.
Zhang, Hua, Jiale Ma, Yue Jiang, et al.. (2024). Monodispersed Iron Selenide Nanoparticles United with Carbon Nanotubes for Highly Reversible Zinc–Air Batteries. SHILAP Revista de lepidopterología. 6(2). 2 indexed citations
5.
Yin, Jianli, Deqiang Kong, Ying Guan, et al.. (2024). A digital CRISPR-dCas9-based gene remodeling biocomputer programmed by dietary compounds in mammals. Cell Systems. 15(10). 941–955.e5. 4 indexed citations
6.
Wang, Meiyan, et al.. (2024). A sensitive red/far-red photoswitch for controllable gene therapy in mouse models of metabolic diseases. Nature Communications. 15(1). 10310–10310. 12 indexed citations
7.
Wu, Xin, Meiyan Wang, Di Dai, et al.. (2024). AAV-delivered muscone-induced transgene system for treating chronic diseases in mice via inhalation. Nature Communications. 15(1). 1122–1122. 8 indexed citations
8.
Kong, Deqiang, Yang Zhou, Wei Yu, et al.. (2024). Exploring plant-derived phytochrome chaperone proteins for light-switchable transcriptional regulation in mammals. Nature Communications. 15(1). 4894–4894. 1 indexed citations
9.
Fischer, Alexandra, Deqiang Kong, Manfred Fliegauf, et al.. (2024). Engineering Material Properties of Transcription Factor Condensates to Control Gene Expression in Mammalian Cells and Mice. Small. 20(38). e2311834–e2311834. 6 indexed citations
10.
Wang, Xinyi, et al.. (2023). Engineering natural molecule-triggered genetic control systems for tunable gene- and cell-based therapies. Synthetic and Systems Biotechnology. 8(3). 416–426. 1 indexed citations
11.
Wang, Xinyi, Liping Kang, Deqiang Kong, et al.. (2023). A programmable protease-based protein secretion platform for therapeutic applications. Nature Chemical Biology. 20(4). 432–442. 17 indexed citations
12.
Strittmatter, Tobias, Yidan Wang, Leo Scheller, et al.. (2022). Programmable DARPin-based receptors for the detection of thrombotic markers. Nature Chemical Biology. 18(10). 1125–1134. 15 indexed citations
13.
Li, Ting, Xianjun Chen, Yajie Qian, et al.. (2021). A synthetic BRET-based optogenetic device for pulsatile transgene expression enabling glucose homeostasis in mice. Nature Communications. 12(1). 615–615. 26 indexed citations
14.
Hörner, Maximilian, O. Sascha Yousefi, Wolfgang W. Schamel, et al.. (2021). Spatiotemporally confined red light-controlled gene delivery at single-cell resolution using adeno-associated viral vectors. Science Advances. 7(25). 20 indexed citations
15.
Wang, Xinyi, Kaili Dong, Deqiang Kong, et al.. (2021). A far-red light–inducible CRISPR-Cas12a platform for remote-controlled genome editing and gene activation. Science Advances. 7(50). eabh2358–eabh2358. 35 indexed citations
16.
Krawczyk, Krzysztof, Shuai Xue, P. Buchmann, et al.. (2020). Electrogenetic cellular insulin release for real-time glycemic control in type 1 diabetic mice. Science. 368(6494). 993–1001. 143 indexed citations
17.
Bai, Peng, Ying Liu, Shuai Xue, et al.. (2019). A fully human transgene switch to regulate therapeutic protein production by cooling sensation. Nature Medicine. 25(8). 1266–1273. 44 indexed citations
18.
Wang, Hui, Mingqi Xie, Ghislaine Charpin‐El Hamri, Haifeng Ye, & Martin Fussenegger. (2018). Treatment of chronic pain by designer cells controlled by spearmint aromatherapy. Nature Biomedical Engineering. 2(2). 114–123. 41 indexed citations
19.
Ye, Haifeng & Martin Fussenegger. (2018). Optogenetic Medicine: Synthetic Therapeutic Solutions Precision-Guided by Light. Cold Spring Harbor Perspectives in Medicine. 9(9). a034371–a034371. 39 indexed citations
20.
Shao, Jiawei, Shuai Xue, Guiling Yu, et al.. (2017). Smartphone-controlled optogenetically engineered cells enable semiautomatic glucose homeostasis in diabetic mice. Science Translational Medicine. 9(387). 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mingqi Xie Breakdown of academic impact, for papers by Hua Gao Breakdown of academic impact, for papers by Laura Mezzanotte Breakdown of academic impact, for papers by Marie Daoud‐El Baba Breakdown of academic impact, for papers by Hongyin Wang Breakdown of academic impact, for papers by Xiaoyu Chen Breakdown of academic impact, for papers by Claudia Seidel Breakdown of academic impact, for papers by F Solomon Breakdown of academic impact, for papers by Jung‐Eun Park Breakdown of academic impact, for papers by Antonella Calogero
Rankless by CCL
2026